Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

In the broader markets, the Nifty Midcap 100 climbed 0.51 per cent and the Nifty Smallcap 100 was higher by 0.42 per cent ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...

U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

The researchers found that drug seizures in San Francisco were associated with a substantial increase in fatal opioid ...

PHARMACEUTICAL company Indies Pharma Jamaica Limited has secured US$405,000 or just over $60 million in its first drawdown ...